Launches Tavalisse Tab. 100Mg And 150Mg, An Oral Spleen Tyrosine Kinase Inhibitor, In Japan For Chronic Itp

Kissei Pharmaceutical

06/04/2023 06:02

April 6 (Reuters) - Kissei Pharmaceutical Co Ltd
 4547.T :
    * KISSEI PHARMACEUTICAL CO LTD: LAUNCHES TAVALISSE TAB.
100MG AND
150MG, AN ORAL SPLEEN TYROSINE KINASE INHIBITOR, IN JAPAN FOR
CHRONIC ITP

Source text for Eikon:  ID:nTSpf84b5f 
Further company coverage:  4547.T 

 (Reporting by Tokyo Newsroom)
 ((+81345201189;))